Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis

BACKGROUND: Palivizumab has been shown to decrease the incidence of hospitalization due to respiratory syncytial virus (RSV) in infants at risk of severe RSV disease. We examined the association between compliance with palivizumab dosing throughout the RSV season and risk of RSV-related hospitalizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Dan L, Ryan, Kellie J, Seare, Jerry G, Pinsky, Brett, Becker, Laura, Frogel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727980/
https://www.ncbi.nlm.nih.gov/pubmed/23870086
http://dx.doi.org/10.1186/1471-2334-13-334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727980/
https://www.ncbi.nlm.nih.gov/pubmed/23870086
http://dx.doi.org/10.1186/1471-2334-13-334

Ejemplares similares